Skip to main content

Table 5 Levels of in vitro resistance for HIV-1 INSTI mutated viruses with elvitegravir resistance pathways

From: HIV drug resistance against strand transfer integrase inhibitors

Genotype

RAL

EVG

DTG

CTG

BIC

T66

T66A

+

NA

T66A/S153F

++

NA

NA

NA

T66I

+

NA

T66I/L74M

+

++

NA

T66I/E92Q

++

+++

NA

T66I/F121Y

+

++

NA

NA

NA

T66I/S153Y

+++

NA

NA

NA

T66I/E157Q

++

NA

T66I/Q146P

NA

+++

NA

NA

NA

T66I/Q146P/S147G

NA

+++

NA

NA

NA

T66I/Q95K/Q146P/S147G

NA

+++

NA

NA

NA

T66I/Q95K/E138K/Q146P/S147G

NA

+++

NA

NA

NA

T66I/T97A/E157Q

++

NA

T66I/R263K

++

NA

NA

T66I/E138K/R263K

+

+++

NA

NA

T66K

+

+++

NA

T66K/L74M

++

+++

+

+

NA

E92

E92G

+

NA

NA

E92G/S153F

+

NA

NA

NA

E92I

+

 

E92Q

+

++

V72I/E92Q/E157Q

+

++

NA

NA

NA

E92Q/S147G

+

NA

NA

NA

H51Y/E92Q/S147G

NA

+++

NA

NA

NA

H51Y/E92Q/S147G/E157Q

NA

+++

NA

NA

NA

E92Q/E157Q

++

++

NA

E92Q/R263K

+

+++

NA

 

E92V

+

NA

  1. Scale: ‘−’ no fold-change (FC), ‘+’ low FC, ‘++’ moderate FC, and ‘+++’ high FC from measured WT 50% inhibitory concentration (EC50). NA denotes no value available. Numbers refer to amino acid position in HIV integrase, one letter amino acid code used
  2. References: [14, 16, 28, 29, 31, 32, 36, 40, 43,44,45, 49,50,51,52, 54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69]